Evolent Health (EVH) Shares Outstanding (Weighted Average) (2013 - 2026)

Evolent Health's Shares Outstanding (Weighted Average) history runs 14 years deep, the most recent figure standing at $111.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 2.96% year-over-year to $111.9 million; the TTM figure through Mar 2026 stood at $111.9 million (down 2.96% YoY), while the FY2025 annual figure was $114.2 million, changed 0.41% from the prior year.
• Shares Outstanding (Weighted Average) was $111.9 million for Q1 2026 at Evolent Health, down from $114.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $115.9 million in Q2 2025 to a low of $89.5 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $108.2 million across 5 years, with a median of $111.9 million in 2026.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Weighted Average) grew 23.54% in 2023, then slipped 2.96% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $93.7 million in 2022, then grew by 18.73% to $111.3 million in 2023, then advanced by 3.08% to $114.7 million in 2024, then decreased by 0.41% to $114.2 million in 2025, then decreased by 2.02% to $111.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $111.9 million (Q1 2026), $114.2 million (Q4 2025), and $114.1 million (Q3 2025), per Business Quant data.